Slide Background

About Us

Who we are

Ikaria Australia Pty Ltd is now a part of Mallinckrodt Pharmaceuticals. Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products. We are focussed on our mission: Managing Complexity. Improving Lives.

Mallinckrodt in Australia is dedicated to support Australian research due to the company's strategic vision of being a valued partner in Critical Care. Currently, INOmax® (nitric oxide) for inhalation and THERAKOS® CELLEX® system using UVADEX® are Mallinckrodt's commercialised products in Australia. We look forward to expanding our product portfolio to address the unmet needs of Australian patients and clinicians in the near future drawing on 150 years of using our unique strengths, experience and expertise to help improve people's lives.

What We Believe In

People throughout the world count on Mallinckrodt products every day to help them lead healthier lives.

For more than 150 years, we have remained focused on producing quality products with the utmost integrity and unparalleled service in order to better serve the patients, customers and communities in which we live and work. Explore the roles of our dedicated employees and our commitment to responsibility.

Our Values

At Mallinckrodt Pharmaceuticals, our Values guide our work and serve as a foundation for our success.

These Values are Patient-Centric, Innovative and Collaborative.


To learn more about Mallinckrodt's culture and what it is like to work here, visit our global Careers site.